Nathan Hipp, VP at National Search Associates, collaborated with Legend Biotech to help them identify and hire their first CEO, marking an important milestone for the newly minted CAR-T biotech. Yuan Xu was previously Sr. Vice President Biologics and Vaccines at Merck where she led Merck Biologics, Biosimilar, & Vaccines discovery, development, commercialization, drug supply, and life-cycle-management activities. Prior, Yuan served in senior roles spanning R&D and manufacturing at Gilead, Novartis, Amgen, and GlaxoSmithKline. Yuan will split time between the Legend Biotech US Headquarters in Piscataway, New Jersey and their business unit in Nanjing, China.

About Legend Biotech

Legend Biotech is a subsidiary of GenScript Biotech Corporation (HKEx: 1548), with its global presence in the United States, Hong Kong, Ireland and Nanjing China. Legend Biotech engages and concentrates on the construction of CAR-T cell therapy platform, and it has built up its own proprietary intellectual property position. Its LCAR-B38M based products have demonstrated outstanding overall response rate (ORR) in a serious of pre-clinical studies treating refractory Multiple Myeloma. At present, around 200+ employees globally located, are committed to continuous research and development processes aiming to provide revolutionary CAR-T and other forms of cell therapies to cancer patients. Learn more at

About GenScript Biotech Corporation

GenScript Biotech Corporation (HKEx: 1548) provides reagents services for researchers in basic life sciences, translational and biomedical fields, as well as pre-clinical antibody drug development, through its global operating entities located in the United States, Hong Kong, Ireland, the Netherlands, Japan and China. The diverse portfolio of GenScript encompasses extensive services in gene synthesis and molecular biology, peptide synthesis, protein expression and engineering, custom antibody development and engineering, in vitro/in vivo pharmacology as well as variety of catalogue products for research. Learn more at

Nathan Hipp, VP at National Search Associates, collaborated with Legend Biotech to hire a new CEO. Yuan has worked at top pharmaceuticals companies from the beginning of her career, starting with Genentech, Glaxo Smith Kline, Chiron and Amgen. She was then the Vice President at Novartis for 8 years as the Global Head of Biotherapeutics, worked at Gilead as their VP and then became SVP at Merck for a couple years. Yuan’s expertise will bring great success for the small biotech company.